R
Raquel González
Researcher at University of Barcelona
Publications - 100
Citations - 2511
Raquel González is an academic researcher from University of Barcelona. The author has contributed to research in topics: Malaria & Pregnancy. The author has an hindex of 26, co-authored 89 publications receiving 2019 citations. Previous affiliations of Raquel González include International Military Sports Council & Central University, India.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial
Salim Abdulla,Issaka Sagara,Steffen Borrmann,Steffen Borrmann,Umberto D'Alessandro,Raquel González,Raquel González,Mary J. Hamel,Bernhards Ogutu,Andreas Mårtensson,Andreas Mårtensson,John Lyimo,Hamma Maiga,Philip Sasi,Alain Nahum,Quique Bassat,Quique Bassat,Elizabeth Juma,Lucas Otieno,Anders Björkman,Anders Björkman,Hans-Peter Beck,Kim Andriano,Marc Cousin,Gilbert Lefèvre,David Ubben,Zulfikarali Premji +26 more
TL;DR: A six-dose regimen of artemether-lumefantrine with the new dispersible formulation is as efficacious as the currently used crushed tablet in infants and children, and has a similar safety profile.
Journal ArticleDOI
The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
Jane Achan,Ishag Adam,Emmanuel Arinaitwe,Elizabeth A. Ashley,Ghulam Rahim Awab,Ghulam Rahim Awab,Mamadou S. Ba,Karen I. Barnes,Quique Bassat,Steffen Borrmann,Steffen Borrmann,Teun Bousema,Teun Bousema,Prabin Dahal,Umberto D'Alessandro,Umberto D'Alessandro,Timothy M. E. Davis,Arjen M. Dondorp,Grant Dorsey,Chris Drakeley,Caterina I. Fanello,Babacar Faye,Jennifer A. Flegg,Oumar Gaye,Peter W. Gething,Raquel González,Philippe J Guerin,Simon I. Hay,Tran Tinh Hien,Tran Tinh Hien,Bart Janssens,Moses R. Kamya,Corine Karema,Harin Karunajeewa,Moussa Koné,Bertrand Lell,Kevin Marsh,Kevin Marsh,Mayfong Mayxay,Mayfong Mayxay,Clara Menéndez,Petra F. Mens,Martin M Meremikwu,Clarissa Moreira,Clarissa Moreira,Ivo Mueller,Ivo Mueller,Carolyn Nabasumba,Michael Nambozi,Jean Louis Ndiaye,Paul N. Newton,Paul N. Newton,Thuy Nguyen,François Nosten,François Nosten,Christian Nsanzabana,Sabah A. Omar,Jean-Bosco Ouédraogo,Louis K. Penali,Mbaye Pene,Aung Pyae Phyo,Patrice Piola,Ric N. Price,Ric N. Price,P. Sasithon,Philip J. Rosenthal,Albert Same-Ekobo,Patrick Sawa,Henk D. F. H. Schallig,Seif Shekalaghe,Carol Hopkins Sibley,Jeff Smith,Frank Smithuis,Anyirékun Fabrice Somé,Kasia Stepniewska,Ambrose O. Talisuna,Joel Tarning,Joel Tarning,Emiliana Tjitra,Roger Tine,Halidou Tinto,Neena Valecha,Michel Van Herp,Michèle van Vugt,Nicholas J. White,Nicholas J. White,Charles J. Woodrow,William Yavo,Adoke Yeka,Issaka Zongo +89 more
TL;DR: In this paper, the influence of different dosing schedules on Dihydroartemisinin-piperaquine (DP) clinical efficacy was investigated, and a multivariable model was used to identify risk factors for parasite recrudescence.
Journal ArticleDOI
A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial
Daniel Atwine,Betty Balikagala,Quique Bassat,Victor Chalwe,Umberto D'Alessandro,Mehul Dhorda,Sarah Donegan,Paul Garner,Raquel González,Robert T. Guiguemdé,Sebastian Hachizovu,Dan Kajungu,Moses R. Kamya,Corine Karema,Afizi Kibuuka,Peter G. Kremsner,Bertrand Lell,Sonia Machevo,Clara Menéndez,Joris Menten,Martin M Meremikwu,Ghyslain Mombo-Ngoma,Fred Mudangha,Modest Mulenga,Tharcisse Munyaneza,Carolyn Nabasumba,Michael Nambozi,Friday Odey,Samson Okello,Chioma Oringanje,Angela Oyo-Ita,Patrice Piola,Raffaella Ravinetto,Halidou Tinto,Noel Rouamba,Fabian Strecker,Ambrose Talisuna,Noella Umulisa,Aline Uwimana,Innocent Valea,Jean-Pierre Van Geertruyden,Harry van Loen,Paula R Williamson,Adoke Yeka +43 more
TL;DR: This large head-to-head comparison of most currently available ACTs in sub-Saharan Africa showed that AL, ASAQ, andDHAPQ had excellent efficacy, up to day 63 post-treatment, supporting the recent recommendation of considering DHAPQ as a valid option for the treatment of uncomplicated P. falciparum malaria.
Journal ArticleDOI
Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial
Raquel González,Ghyslain Mombo-Ngoma,Smaïla Ouédraogo,Mwaka A. Kakolwa,Salim Abdulla,Manfred Accrombessi,John J. Aponte,Daisy Akerey-Diop,Arti Basra,Valérie Briand,Meskure Capan,Michel Cot,Abdunoor M. Kabanywanyi,Christian Kleine,Peter G. Kremsner,Eusebio Macete,Jean-Rodolphe Mackanga,Achille Massougbodgi,Alfredo Mayor,Arsenio Nhacolo,Golbahar Pahlavan,Michael Ramharter,María Rupérez,Esperança Sevene,Anifa Vala,Rella Zoleko-Manego,Clara Menéndez +26 more
TL;DR: An open-label randomized controlled trial in HIV-negative pregnant women in Benin, Gabon, Mozambique, and Tanzania to evaluate the safety and efficacy of mefloquine compared to sulfadoxine-pyrimethamine for intermittent preventative therapy for malaria.
Journal ArticleDOI
High HIV prevalence in a southern semi-rural area of Mozambique: a community-based survey.
Raquel González,Raquel González,Khátia Munguambe,John J. Aponte,John J. Aponte,C Bavo,Delino Nhalungo,Eusebio Macete,Pedro L. Alonso,Pedro L. Alonso,Clara Menéndez,Clara Menéndez,Denise Naniche,Denise Naniche +13 more
TL;DR: Southern African countries have borne the brunt of the HIV/AIDS pandemic and monitoring epidemiological dynamics is critical to identify the populations at greatest risk of infection and to guide control strategies.